INMD - InMode Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
27.29
-0.46 (-1.66%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close27.75
Open28.01
Bid0.00 x 1000
Ask0.00 x 2200
Day's Range26.53 - 28.01
52 Week Range13.06 - 29.38
Volume376,149
Avg. Volume1,141,300
Market Cap872.56M
Beta (3Y Monthly)N/A
PE Ratio (TTM)27.90
EPS (TTM)0.98
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.00
Trade prices are not sourced from all markets
  • InMode's Inaugural Insider Summit Attracts Over 600 Attendees
    PR Newswire

    InMode's Inaugural Insider Summit Attracts Over 600 Attendees

    LAKE FOREST, Calif. , Sept. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode"), a leading global provider of innovative medical technologies, hosted over 600 physicians and medical ...

  • Drugmakers Drag On Nasdaq Index, Dow Jones Today; Early Risers: AT&T, InMode, RH
    Investor's Business Daily

    Drugmakers Drag On Nasdaq Index, Dow Jones Today; Early Risers: AT&T, InMode, RH

    AT&T;, RH and InMode climbed early Monday. The S&P; 500 and Dow Jones today aimed to add a fourth day to their rallies, and the Nasdaq index eyed a rebound.

  • Three technology stocks to watch include Twitter
    MarketWatch

    Three technology stocks to watch include Twitter

    Three technology companies, plus a medical-device maker, are showing strong technical momentum. Lattice Semiconductor Corp. (LSCC) gained 53 cents to $19.73 on 1.8 million shares traded Thursday. The move, on no news from the company and following through on Wednesday’s rally, positioned the stock at the top of its five-week sideways channel.

  • Dow Jones Today: Intel Leads Chip Rally As China Trade Hopes Rise
    Investor's Business Daily

    Dow Jones Today: Intel Leads Chip Rally As China Trade Hopes Rise

    Signals of progress in U.S. China trade talks boosted stock futures Thursday, but can the market break above month-long resistance?

  • Paula Abdul Backs This Medical IBD Stock Of The Day — Here's Why
    Investor's Business Daily

    Paula Abdul Backs This Medical IBD Stock Of The Day — Here's Why

    InMode is the IBD Stock Of The Day as the medical aesthetics player rockets 60% above its initial public offering just last month. The market is led by Allergan, soon to merge with AbbVie.

  • Why InMode Shares Surged 12.9% Today
    Motley Fool

    Why InMode Shares Surged 12.9% Today

    Wall Street is increasingly optimistic about this medical device company.

  • InMode to Participate in 5CC International Conference in Barcelona
    PR Newswire

    InMode to Participate in 5CC International Conference in Barcelona

    YOQNEAM, Israel, Aug. 27, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, will participate in the 5CC (5 Continent-Congress) in the field of medical and aesthetic dermatology. Drs. Arroyo and Estrada from Spain will be presenting the latest data on Votiva, InMode's breakthrough technology for feminine wellness and genital treatments. In addition, InMode luminaries from the United States, will travel to present their clinical research regarding InMode's minimally invasive and non-invasive aesthetic technologies.

  • InMode Ltd. Announces Exercise of Over-Allotment Option
    PR Newswire

    InMode Ltd. Announces Exercise of Over-Allotment Option

    LAKE FOREST, Calif., Aug. 20, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") announced today the issuance and sale of an additional 500,000 ordinary shares pursuant to the partial exercise of the underwriters' over-allotment option in connection with InMode's initial public offering. The additional shares were sold at the initial offering price of $14.00 per ordinary share, generating additional gross proceeds of approximately $7.0 million and bringing the total gross proceeds to InMode from the offering, before deducting underwriting discounts and commissions and other offering expenses, to approximately $77.0 million.

  • Paula Abdul-Backed Medical IPO Goes Straight Up For Second Day
    Investor's Business Daily

    Paula Abdul-Backed Medical IPO Goes Straight Up For Second Day

    InMode stock popped for a second day running Thursday after the Paula Abdul-backed medical aesthetics company reported strong revenue growth in the second quarter ended June 30.

  • Why Purple Innovation, Presidio, and InMode Jumped Today
    Motley Fool

    Why Purple Innovation, Presidio, and InMode Jumped Today

    Good news from these companies helped them avoid a big market sell-off.

  • InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 Million Reflects Growth of 55% Over Prior Year
    PR Newswire

    InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 Million Reflects Growth of 55% Over Prior Year

    Net Income Increased 109% Over Prior Year to $15.8 Million InMode Completed a Successful Initial Public Offering with Gross Proceeds of $70 Million LAKE FOREST, Calif. , Aug. 13, 2019 /PRNewswire/ -- InMode ...

  • Paula Abdul Announced as InMode Brand Ambassador
    PR Newswire

    Paula Abdul Announced as InMode Brand Ambassador

    LAKE FOREST, Calif., Aug. 13, 2019 /PRNewswire/ -- International Pop Icon Paula Abdul has made her mark in this industry as an award-winning dancer and choreographer, singer, actress, and television personality with six number-one singles on the Billboard Hot 100, Emmy and Grammy Awards, and numerous other accolades. Paula has agreed to join InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company") as a brand ambassador to share her positive experience with the Company's BodyTite, FaceTite and Morpheus8 technologies.

  • InMode Ltd. Announces Closing of Initial Public Offering
    PR Newswire

    InMode Ltd. Announces Closing of Initial Public Offering

    LAKE FOREST, Calif., Aug. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode") announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The aggregate gross proceeds, before deducting underwriting discounts and commissions and other offering expenses, to InMode from the offering were approximately $70.0 million. Barclays Capital Inc. and UBS Securities LLC acted as the representatives of the underwriters and joint book-running managers for the offering.

  • InMode Ltd. Announces Pricing of Initial Public Offering
    PR Newswire

    InMode Ltd. Announces Pricing of Initial Public Offering

    LAKE FOREST, Calif., Aug. 7, 2019 /PRNewswire/ -- InMode Ltd. ("InMode"), announced today the pricing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The underwriters of the offering will also have a 30-day option to purchase up to an additional 750,000 ordinary shares from InMode at the initial public offering price.

  • Benzinga

    Inmode IPO: What You Need To Know

    A medical aesthetic company is testing the IPO waters this week. Will investment in the shares give a facelift? The IPO Terms Yokneam, Israel-based Inmode Ltd. has filed with the SEC a preliminary prospectus ...

  • MARKETS: Nasdaq, Apple and Inmode looking bullish
    Yahoo Finance Video

    MARKETS: Nasdaq, Apple and Inmode looking bullish

    Alissa Coram, Multimedia Content Editor at Investor's Business Daily, joins Yahoo Finance's Myles Udland and Jared Blikre to break down the price action in these three markets.